Track Categories
The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Drug discovery is the process of finding novel drugs or medicines are discovered and aims to identify a compound therapeutically useful for treating and curing disease. It encompasses several different scientific fields, including as biology, chemistry, and pharmacology. One of the initial steps in the drug discovery process typically involves screening a large number of compounds to see if they have the desired biochemical or cellular effects. Methods to make this screening quicker, more efficient, and less expensive are constantly being developed.
Pharmaceutics are one of the primary factors for developing a drug as it involves in converting a new chemical entity to a completely novel product which can be used for the treatment of any particular disease. Pharmaceutics is one of the major components that is taken into consideration while developing a novel drug as it primarily involves in predicting the perfect amount of dosage that is necessary for an individual to get treated for the specific condition.
Nanotechnology is one of the most well-recognized and well utilized domains across various fields which provide a positive solution at a Nano-level for every product. Nanomedicine is one of the currently developing domains of nanotechnology sector in which the nano-based solutions are being developed for developing medicinal devices, sensors and much more. Other than being involved in developing material-based products, some of the nano-based solutions are being utilized on the developments of drug particles and much more. Toxicity and other disadvantages comes into place as a result of it but it is one of the more advanced and fast growing solutions in the domain of pharmaceutics.
For a drug that is being developed and to be introduced on to a market, some of the pre-determining factors for a drug to be taken into account are the mode of delivery in which the drug is being introduced to an individual and the way the lead particle has its influence in reducing the damage caused by the virus and helps in aiding the betterment of the individual. These therapeutics agents that are being designed have the potential to tackle any complications that occur within the human body and the type of delivery determines the efficacy and activity of such compounds.
Artificial Intelligence is one of the current advanced ways of indulging machine level solutions to the existing problems which are difficult or takes much time while tackling through natural means. In recent years, Artificial Intelligence has found its way on the Pharmaceutical sector and providing cutting-edge solutions to some of the leading pharmaceutical companies around the world.
Biology is one of the vast domains in the sector of general science which helps in understanding the nature of human and animal system as to how they will function as a whole and helps in understanding the basic aspect of living. Bionanomaterials is one of the promising and advanced research innovations in the domain of Pharmaceutics which involves the utilization of biological materials such as cells and nucleic acids to develop them to an organic or inorganic material which has a wide variety of properties in tackling some complex conditions.
Nanotechnology is one of the most intriguing yet exiting sectors which seem to find its place on any sector from medicine to industry. The involvement of nanotechnology on the field of medicine is one of the complicated challenges for the researchers as the results of involving nanotechnology in pharmaceuticals were tough in the beginning. However, in recent years, nanotechnology has taken the world of pharmaceutics by storm by providing quality solutions to some of the difficulties which are faced by the industries over the years.
Drug formulation is one of the key factors and the first primary step that is to be taken into consideration as it determines the overall composition of the how the drug is needed to be made so that it can perform the activity which it needs to perform. As the drugs are to be taken by humans during the clinical trials the drug is needed to be designed in such a way that it won’t cause any damages to the system. The process involves the usage of Active Pharmaceutical Ingredient (API) which is the novel product that is set to treat the condition is added along with some excipients, which are highly inactive and helps in aiding the API to reach the potential treatment place before the API gets wasted on places other than the site of damage.
Vaccines are chemical or biological compounds which are given to individuals to enact an immune response against a certain disease. Vaccines help in activating the immune response by the cells against particular diseases so if they were to attack the system again, the human system will respond to the vaccines at a faster rate and eliminate the threat before it develops and takes over the human system. With the pharmaceutical companies were less interested in developing vaccines during the late 2018’s, the threat of COVID-19 enabled every industry to develop a novel vaccine as it is a disease that has never been tackled before. Major Pharmaceutical companies have started to put more effort on developing vaccines and set to take their place as one of the pioneers in this domain.
Radiopharmaceuticals are one in which radioactive agents are used to diagnose or to treat a particular disease condition. The usage of radioactive agents for treating any condition seems complex and may cause some damages to the system however, if they are to be used on smaller amount for diagnostic purposes, they are considered to be safe and is they are to be used to treatment, larger amount of radioactive materials are needed and thereby causing some lasting side-effects to the system.
Pharmacology is a major study that comes under the domain of pharmaceutical sciences which intends to study the action of the drug which enters the system. Pharmacology defines the interaction between the chemicals and the human system and how it influences treating the disease. The pharmacology studies help in understanding the optimal level of drug composition needed to treat disease and the way the drug needs to be designed so it may be enough to treat the complexion within the system. This is the major step that is to be followed before the production of the drugs on a larger scale.
Pharmaceutical biotechnology is a novel and innovative process in which the concept of Biotechnology is integrated with pharmaceutical studies to develop a novel and innovative drug product. The current market is filled with bio-tech-developed products (bio-formulations) such as vaccines, antibodies, nucleic acid products, etc. One of the major product developments that are derived through this domain involves removing and altering our own cells and directing our system to eliminate the disease. This method is found successful and now nearly 51% of the biotechnology-related solutions are used by health care and pharmaceutical domains.
The science of drug movement is known as pharmacokinetics. Pharmacokinetics is one of the two major fields of study that comprise the scientific discipline of pharmacology. The application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient is referred to as clinical pharmacokinetics. Clinical pharmacokinetics involves improving the efficacy and lowering the toxicity of a patient's drug therapy. The discovery of strong correlations between drug concentrations and pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to real-world patient situations. In pharmacokinetics, four phases are involved.
Absorption
Distribution
metabolism
excretion
Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the human body, and it includes concepts such as receptor binding, postreceptor effects, and chemical interactions.The study of pharmacodynamics is the second of two branches included in the scientific discipline of pharmacology.It is the quantitative investigation of the relationship between drug exposure and the drug's pharmacologic and toxic effects.Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, which includes the time course and intensity of therapeutic and adverse effects
Pharmacoepidemiology is the study of medication utilisation and effects in large human populations, bridging clinical pharmacology and epidemiology.It calculates the risks and benefits of medication use on a variety of important physical and mental health outcomes.Pharmacoepidemiology research is critical for identifying rare but severe adverse outcomes after a drug is marketed; studying risks and benefits in populations excluded from randomised clinical trials; and is increasingly being used for public health and clinical decisions.
Pharmacogenomics (also known as pharmacogenetics) is the study of how a person's genes influence how he or she responds to medications.Its long-term goal is to assist doctors in selecting the drugs and dosages that are best suited for each individual.It falls under the purview of precision medicine, which seeks to treat each patient on an individual basis.The study of differential gene-expression profiles in tissues of interest and their relationship to drug-response phenotypes is referred to as pharmacogenomics.The field of pharmacogenomics is concerned with treatment efficacy, dosing, and safety.Pharmacogenomics is regarded as a critical future area for improving drug therapy and prescribing.
Nutraceuticals is an improving domain in the pharmaceutical sector in which the product (drug) is derived from the food sources thereby adding additional health benefits to the ones consuming and also improving the nutritional values of the individuals who are using such products. The products that are derived from the nutraceutical domain helps in maintaining a healthy human system, controlling any symptoms from diseases that may have arisen before and also prevent the system from having any malignant process in the system.
Toxicology also referred to as “Science of Safety” is a practice that is being followed by the Pharmaceutical sectors around the world to identify the safety level of the chemical products or drugs before getting developed at a larger scale. The process of drug production involves using chemicals that are not familiar with the human system and are considered harmful. Toxicology studies analyses such drugs or chemicals and details the info regarding the potential uses or harms it may cause to the public. The toxicology process is essential in the process of drug development as even a minor increase in any of those chemical components will gravely affect the human system.
The most recent uses of nanotechnology in the field of surgery are in the development of surgical implants using nanomaterials such as imaging, drug delivery, and tissue engineering products. Dental research has been conducted in the areas of nanotechnology and liposomal Collagenase-containing nanoparticles have been studied in rats and found to reduce collagen fibre more quickly than standard surgery, allowing teeth to move more easily with braces.